|
| << vorige | volgende >> |
Tijdschrift beschrijving
Alle jaargangen van het bijbehorende tijdschrift
Alle afleveringen van het bijbehorende jaargang
Alle artikelen van de bijbehorende aflevering
Details van artikel 4 van 7 gevonden artikelen
| Titel: |
Decreased Levels of Amyloid-β 1-42 in Cerebrospinal Fluid of Creutzfeldt.Jakob Disease Patients |
| Auteur: |
Van Everbroeck, B. Green, A.J.E. Pals, Ph. Martin, J.J. Cras, P. |
| Verschenen in: |
Journal of Alzheimer's disease |
| Paginering: | Jaargang 1 (2001) nr. 6 pagina's 419-424 |
| Jaar: |
2001-04-01 |
| Inhoud: |
Creutzfeldt-Jakob disease (CJD) is a rare neurodegenerative disease caused by the prion protein. In the search for biochemical markers for CJD, cerebrospinal fluid (CSF) of 101 patients was analysed for 14-3-3 protein, hTau-protein and amyloid- β 1-42 (Aβ1-42). The 14-3-3 test had a specificity of 91.5% and a sensitivity of 84%. The hTau test resulted in 95% specificity and 74% sensitivity, when a cut-off of 1530 pg/ml was used. Aβ1-42 detection in CSF of 29 probable or definite CJD patients revealed significantly decreased values (p = 0.01) compared to a group of 22 neurological controls. In the CJD patients a mean of 319 ± 102 pg/ml was found. In the neurological control group a mean of 553 ± 268 pg/ml was observed. In patients with a false positive 14-3-3 test (n = 5) a mean of 716 ± 441 pg/ml was found. We conclude that determination of Aβ1-42 levels in CSF can be useful for identifying false positive 14-3-3 results in suspected CJD patients. We also compared the presence of senile plaques and the Aβ1-42 levels in CSF of CJD patients. No clear correlation between them was found in this series. This signifies that the deceased Aβ1-42 levels in CSF are not just due to plaque retention but that other mechanisms must also play a role. |
| Uitgever: |
IOS Press |
| Bronbestand: |
Elektronische Wetenschappelijke Tijdschriften |
Details van artikel 4 van 7 gevonden artikelen
| << vorige | volgende >> |